Obesity, a growing global epidemic, is identified as a significant, modifiable risk factor for ovarian cancer, a deadly ...

LeptiCell’s rise coincides with macro trends across both the health supplement and weight management industries. According to ...

Leptin is produced by adipocytes in response to increased trigyceride storage, and appears to affect body weight primarily through target cells in the hypothalamus.

Medically reviewed by Kelly Wood, MD Hormones play a major role in energy usage and storage, metabolism, growth, and fat distribution. When hormone levels shift, unexpected weight gain may occur.

In a world that often glorifies all-nighters and nonstop hustle, sleep is frequently undervalued. But as the research ...

Neuropeptide Y (NPY), a 36-amino-acid peptide widely expressed in the brain1 is involved in many physiological responses2, including hypothalamic control of food intake and cardiovascular homeostasis.

Claudin-18 isoform 2 (CLDN18.2) has emerged as a promising therapeutic target in gastric or gastro-oesophageal junction cancer. Satricabtagene autoleucel (satri-cel; also known as CT041), an ...

The U.S. health secretary said people should have access to experimental therapies including unregulated uses of stem cells. But some methods have resulted in blindness, tumors and other injuries.

Scripps’ lung medicine activates stem cells in the lower airways, known as type 2 alveolar epithelial (AEC2) cells, responsible for manufacturing crucial cells for exchanging stale oxygen for fresh.

LONDON — What if the secret to staying young wasn’t another costly cream or trendy supplement, but tamping down a messy kind of cell death that has flown under the radar? A new study argues that ...

An international research team has observed a significant increase in series resistance in LECO-treated TOPCon solar cells after temperature and bias treatment. The scientists said they now need ...

Tarlatamab, a bispecific delta-like ligand 3–directed T-cell engager immunotherapy, received accelerated approval for the treatment of patients with previously treated small-cell lung cancer.